Michael P. Canty
Michael P. Canty prosecutes complex fraud cases on behalf of institutional investors and consumers. Currently, Michael is investigating potential claims brought by state and local governments against large companies in the widespread opioid epidemic. Recommended by The Legal 500 in the field of securities litigation, Michael also is an accomplished litigator with more than a decade of trial experience in matters relating to national security, white collar crime, and cybercrime.
Prior to joining Labaton Sucharow, Michael was a federal prosecutor in the United States Attorney’s Office for the Eastern District of New York, where he served as the Deputy Chief of the Office’s General Crimes Section. Michael also served in the Office’s National Security and Cybercrimes Section. During his time as lead prosecutor, Michael investigated complex and high-profile white collar, national security, and cybercrime offenses. He also served as an Assistant District Attorney for the Nassau County District Attorney’s Office, where he handled complex state criminal offenses.
Michael has extensive trial experience both from his days as a prosecutor in New York City for the United States Department of Justice and during his six years as an Assistant District Attorney. He served as trial counsel in more than 35 matters, many of which related to violent crime, white collar and terrorism related offenses. He played a pivotal role in United States v. Abid Naseer, where he prosecuted and convicted an al-Qaeda operative who conspired to carry out attacks in the United States and Europe. Michael also led the investigation in United States v. Marcos Alonso Zea, a case in which he successfully prosecuted a citizen for attempting to join a terrorist organization in the Arabian Peninsula and for providing material support intended for planned attacks.
Michael also has a depth of experience investigating and prosecuting cases involving the distribution of prescription opioids. In January 2012, Michael was assigned to the U.S. Attorney's Office Prescription Drug Initiative to mount a comprehensive response to what the United States Department of Health and Human Services’ Center for Disease Control and Prevention has called an epidemic increase in the abuse of so-called opioid analgesics. As a member of the initiative, in United States. v. Conway and United States v. Deslouches Michael successfully prosecuted medical professionals who were illegally prescribing opioids. In United States v. Moss et al. he was responsible for dismantling one of the largest oxycodone rings operating in the New York metropolitan area at the time. In addition to prosecuting these cases, Michael spoke regularly to the community on the dangers of opioid abuse as part of the Office’s community outreach.
Before becoming a prosecutor, Michael worked as a Congressional Staff Member for the United States House of Representatives. He primarily served as a liaison between the Majority Leader’s Office and the Government Reform and Oversight Committee. During his time with the House of Representatives, Michael managed congressional oversight of the United States Postal Service and reviewed and analyzed counter-narcotics legislation as it related to national security matters.
St. John's University School of Law
J.D., cum laude, 2004
Mary Washington College
B.A., cum laude, 1999
2005, New York
U.S. Court of Appeals
2010, Second Circuit
U.S. District Court
2010, Eastern District of New York
In the News
- Chicago Tribune, Arizona Drug Company May Pay Illinois $4.5M Over Opioid Lawsuit (08/04/2017)
- Vox, U.S. Officials Are Starting to Treat Opioid Companies Like Big Tobacco — and Suing Them (06/07/2017)
- The New York Times, Ohio Sues Drug Makers, Saying They Aided Opioid Epidemic (05/31/2017)
- Press Release, Labaton Sucharow Earns High Marks in the 2017 Legal 500 Guide (05/31/2017)
- Chicago Tribune, Southern Illinois County Sues Abbott Over Marketing's Role in Opioid Epidemic (04/21/2017)
- The Washington Post, Opioid Distributors Sued by West Virginia Counties Hit by Drug Crisis (03/09/2017)